HIMS
Price
$32.96
Change
-$0.58 (-1.73%)
Updated
Jun 23 closing price
Capitalization
7.63B
47 days until earnings call
Intraday BUY SELL Signals
RAY
Price
$2.87
Change
+$0.03 (+1.06%)
Updated
Jun 23 closing price
Capitalization
7.81M
Intraday BUY SELL Signals
Interact to see
Advertisement

HIMS vs RAY

HIMS vs RAY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HIMS vs. RAY commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIMS is a Hold and RAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (HIMS: $32.96 vs. RAY: $2.87)
Brand notoriety: HIMS and RAY are both not notable
HIMS represents the Pharmaceuticals: Generic, while RAY is part of the Household/Personal Care industry
Current volume relative to the 65-day Moving Average: HIMS: 50% vs. RAY: 33%
Market capitalization -- HIMS: $7.63B vs. RAY: $7.81M
HIMS [@Pharmaceuticals: Generic] is valued at $7.63B. RAY’s [@Household/Personal Care] market capitalization is $7.81M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The market cap for tickers in the [@Household/Personal Care] industry ranges from $351.29B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.96B. The average market capitalization across the [@Household/Personal Care] industry is $22.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HIMS’s FA Score shows that 0 FA rating(s) are green whileRAY’s FA Score has 0 green FA rating(s).

  • HIMS’s FA Score: 0 green, 5 red.
  • RAY’s FA Score: 0 green, 5 red.
According to our system of comparison, RAY is a better buy in the long-term than HIMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HIMS’s TA Score shows that 6 TA indicator(s) are bullish while RAY’s TA Score has 2 bullish TA indicator(s).

  • HIMS’s TA Score: 6 bullish, 4 bearish.
  • RAY’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, HIMS is a better buy in the short-term than RAY.

Price Growth

HIMS (@Pharmaceuticals: Generic) experienced а +4.73% price change this week, while RAY (@Household/Personal Care) price change was -7.58% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.76%. For the same industry, the average monthly price growth was -0.03%, and the average quarterly price growth was +7.54%.

The average weekly price growth across all stocks in the @Household/Personal Care industry was -2.00%. For the same industry, the average monthly price growth was +8.97%, and the average quarterly price growth was -6.25%.

Reported Earning Dates

HIMS is expected to report earnings on Aug 10, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.76% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Household/Personal Care (-2.00% weekly)

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HIMS($7.63B) has a higher market cap than RAY($7.81M). HIMS has higher P/E ratio than RAY: HIMS (57.14) vs RAY (3.82). RAY YTD gains are higher at: 45.431 vs. HIMS (1.509). HIMS has higher annual earnings (EBITDA): 37.6M vs. RAY (10.5M). HIMS has higher revenues than RAY: HIMS (2.37B) vs RAY (78.7M).
HIMSRAYHIMS / RAY
Capitalization7.63B7.81M97,720%
EBITDA37.6M10.5M358%
Gain YTD1.50945.4313%
P/E Ratio57.143.821,497%
Revenue2.37B78.7M3,011%
Total Cash751MN/A-
Total Debt1.13BN/A-
FUNDAMENTALS RATINGS
HIMS: Fundamental Ratings
HIMS
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
75
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
79
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HIMSRAY
RSI
ODDS (%)
Bearish Trend 1 day ago
73%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
86%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HIMS
Daily Signal:
Gain/Loss:
RAY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DTST3.410.09
+2.71%
Data Storage Corp
HOV127.491.90
+1.51%
Hovnanian Enterprises
FICO1099.418.56
+0.78%
Fair Isaac Corp
MNDY70.00-0.37
-0.52%
monday.com Ltd
TLYS4.45-0.25
-5.32%
Tilly's

HIMS and

Correlation & Price change

A.I.dvisor tells us that HIMS and COTY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HIMS and COTY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIMS
1D Price
Change %
HIMS100%
-1.73%
COTY - HIMS
31%
Poorly correlated
+2.62%
IPAR - HIMS
24%
Poorly correlated
+1.83%
HNST - HIMS
23%
Poorly correlated
+3.59%
NBIX - HIMS
23%
Poorly correlated
-0.09%
ALKS - HIMS
22%
Poorly correlated
+4.43%
More

RAY and

Correlation & Price change

A.I.dvisor tells us that RAY and DSY have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RAY and DSY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAY
1D Price
Change %
RAY100%
+0.88%
DSY - RAY
13%
Poorly correlated
-6.11%
GROV - RAY
6%
Poorly correlated
+1.67%
KVUE - RAY
4%
Poorly correlated
+3.08%
WALD - RAY
2%
Poorly correlated
-1.24%
HIMS - RAY
0%
Poorly correlated
-1.73%
More